-
Your selected country is
Japan
- Change country/language
-
抗体試薬
- フローサイトメトリー用試薬
-
ウェスタンブロッティング抗体試薬
- イムノアッセイ試薬
-
シングルセル試薬
- BD® AbSeq Assay | シングルセル試薬
- BD Rhapsody™ Accessory Kits | シングルセル試薬
- BD® Single-Cell Multiplexing Kit | シングルセル試薬
- BD Rhapsody™ Targeted mRNA Kits | シングルセル試薬
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit | シングルセル試薬
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
-
細胞機能評価のための試薬
-
顕微鏡・イメージング用試薬
-
細胞調製・分離試薬
-
- BD® AbSeq Assay | シングルセル試薬
- BD Rhapsody™ Accessory Kits | シングルセル試薬
- BD® Single-Cell Multiplexing Kit | シングルセル試薬
- BD Rhapsody™ Targeted mRNA Kits | シングルセル試薬
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit | シングルセル試薬
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- Japan (Japanese)
- Change country/language
Old Browser
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
BD™ Cytometric Bead Array (CBA) Human IL-2 Standard
(RUO)
Regulatory Statusの凡例
Becton, Dickinson and Companyの書面による明示的な許諾を得た使用以外での製品の使用は固く禁じられています。
説明
This product contains lyophilized recombinant human Interleukin-2 (IL-2). When reconstituted, this product can be used as a standard control with the BD™ CBA Human IL-2 Flex Set (Cat. No. 558270) or with the BD™ CBA Human IL-2 Enhanced Sensitivity Flex Set (Cat. No. 561517). Please refer to the technical data sheet included with the BD™ CBA Human IL-2 Flex Set or the BD™ CBA Human IL-2 Enhanced Sensitivity Flex Set for further information.
調製と保管タイトルテキスト
Lyosphere(s) from 1 vial of Human IL-2 Standard, when reconstituted in 4.0 mL Assay Diluent, approximates the CBA activity of Human IL-2 at a concentration of 2500 pg/mL. Following reconstitution, maintain the Human IL-2 at 4°C and use within 12 hours. Any unused reconstituted standard must be discarded after this period (do not store or reuse).
推奨アッセイ手順
The Human IL-2 Standard has been tested to assure to function as a standard when used with the BD™ Cytometric Bead Array (CBA). Investigators are encouraged to refer to the technical data sheet for the BD™ CBA Human IL-2 Flex Set (Cat. No. 558270) or the BD™ CBA Human IL-2 Enhanced Sensitivity Flex Set (Cat. No. 561517). The Human IL-2 Standard is lyophilized and should be reconstituted and serially diluted before mixing with CBA capture beads and PE detection reagents. An abbreviated instruction has been provided below (Preparation of Human IL-2 Standard Protocol). The Human IL-2 Standard should be reconstituted using Assay Diluent, which is provided with the BD™ CBA Human Soluble Protein Master Buffer Kit (Cat. No. 558264 or 558265), the BD™ CBA Human Enhanced Sensitivity Master Buffer Kit (Cat. No. 561521 or 561523) or it may also be purchased separately (Cat. No. 560104).
Preparation of Human IL-2 Standard for use with the BD™ CBA Human IL-2 Flex Set (Cat. No. 558270):
1. Open one vial of the lyophilized Human IL-2 Standard. Transfer the lyosphere(s) to a polypropylene tube (BD Falcon™, Cat. No. 352097). Label the tube "Top Standard".
2. Reconstitute the standard with 4.0 mL of Assay Diluent. Allow the reconstituted standard to equilibrate for at least 15 minutes before making dilutions. Mix the reconstituted protein by pipette only. Do not vortex or mix vigorously.
3. Label additional 12 x 75 mm tubes (BD Falcon™, Cat. No. 352008) and arrange them in the following order: Top Standard, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128, and 1:256.
4. Add 500 µl of Assay Diluent to each of the dilution tubes.
5. Perform a serial dilution by transferring 500 µl from the Top Standard to the 1:2 dilution tube and mix thoroughly. Do not vortex, mix by pipet only. Continue making serial dilutions by transferring 500 µl from the 1:2 tube to the 1:4 tube and so on to the 1:256 tube and mix thoroughly. Prepare one tube containing only Assay Diluent to serve as the 0 pg/mL negative control.
Preparation of Human IL-2 Standard for use with the BD™ CBA Human IL-2 Enhanced Sensitivity Flex Set (Cat. No. 561517):
1. Open one vial of the lyophilized Human IL-2 Standard. Transfer the lyosphere(s) to a polypropylene tube (BD Falcon™, Cat. No. 352097).
2. Reconstitute the standard with 4.0 mL of Assay Diluent. Allow the reconstituted standard to equilibrate for at least 15 minutes before making dilutions. Mix the reconstituted protein by pipette only. Do not vortex or mix vigorously.
3. Label additional 12 x 75 mm tubes (BD Falcon™, Cat. No. 352008) and arrange them in the following order: Top Standard, 1:3, 1:9, 1:27, 1:81, 1:243, and 1:729.
4. Add 460 µl of Assay Diluent into the Top Standard tube.
5. Add 400 µl of Assay Diluent to each of the remaining dilution tubes.
6. Transfer 40 µl of the reconstituted standard into the Top Standard tube. Mix by pipette or gently vortexing for no longer than 3 seconds.
7. Perform a serial dilution by transferring 200 µl from the Top Standard to the 1:3 dilution tube and mix thoroughly. Do not vortex, mix by pipet only. Continue making serial dilutions by transferring 200 µl from the 1:3 tube to the 1:9 tube and so on to the 1:729 tube and mix thoroughly. Prepare one tube containing only Assay Diluent to serve as the 0 fg/mL negative control.
製品通知
- ProClin is a trademark of Rohm and Haas Company.
- This product is manufactured and sold under license from Pestka Biomedical Laboratories, Inc. (d/b/a PBL InterferonSource) and may be used solely as indicated. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics is strictly prohibited. This product is covered by U.S. Patent No. 5,597,901 and Bulgarian Patent No. BG1895.
- Source of all serum proteins is from USDA inspected abattoirs located in the United States.
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- Warning: CBA lyophilized standard contains 0.02% (w/w) and Detection Reagent (Part A) contains 0.002% (w/w) of a CMIT/MIT mixture (3:1), which is a mixture of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC No 247-500-7] and 2-methyl-4-isothiazolin-3-one [EC No 220-239-6] (3:1).Hazard statement: May cause an allergic skin reaction.Precautionary statements: Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves/eye/face protection. Wear protective clothing. Avoid breathing mist/vapours/spray. If skin irritation or rash occurs: Get medical advice/attention. IF ON SKIN: Wash with plenty of water. Take off contaminated clothing and wash it before reuse. Dispose of contents/container in accordance with local/regional/national/international regulations.
コンパニオン製品
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.